Protocols for Culturing and Imaging a Human <i>Ex Vivo</i> Osteochondral Model for Cartilage Biomanufacturing Applications

oleh: Serena Duchi, Stephanie Doyle, Timon Eekel, Cathal D. O’Connell, Cheryl Augustine, Peter Choong, Carmine Onofrillo, Claudia Di Bella

Format: Article
Diterbitkan: MDPI AG 2019-02-01

Deskripsi

Cartilage defects and diseases remain major clinical issues in orthopaedics. Biomanufacturing is now a tangible option for the delivery of bioscaffolds capable of regenerating the deficient cartilage tissue. However, several limitations of <i>in vitro</i> and experimental animal models pose serious challenges to the translation of preclinical findings into clinical practice. <i>Ex vivo</i> models are of great value for translating <i>in vitro</i> tissue engineered approaches into clinically relevant conditions. Our aim is to obtain a viable human osteochondral (OC) model to test hydrogel-based materials for cartilage repair. Here we describe a detailed step-by-step framework for the generation of human OC plugs, their culture in a perfusion device and the processing procedures for histological and advanced microscopy imaging. Our <i>ex vivo</i> OC model fulfils the following requirements: the model is metabolically stable for a relevant culture period of 4 weeks in a perfusion bioreactor, the processing procedures allowed for the analysis of 3 different tissues or materials (cartilage, bone and hydrogel) without compromising their integrity. We determined a protocol and the settings for a non-linear microscopy technique on label free sections. Furthermore, we established a clearing protocol to perform light sheet-based observations on the cartilage layer without the need for tedious and destructive histological procedures. Finally, we showed that our OC system is a clinically relevant in terms of cartilage regeneration potential. In conclusion, this OC model represents a valuable preclinical <i>ex vivo</i> tool for studying cartilage therapies, such as hydrogel-based bioscaffolds, and we envision it will reduce the number of animals needed for <i>in vivo</i> testing.